These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 2650112)

  • 1. Tolerance induction to murine class II MHC molecules by anti-CD4 antibody.
    Wheelahan J; McKenzie IF
    Transplant Proc; 1989 Feb; 21(1 Pt 1):246-7. PubMed ID: 2650112
    [No Abstract]   [Full Text] [Related]  

  • 2. Bidirectional blockade of CD4 and major histocompatibility complex class II molecules: an effective immunosuppressive treatment in the mouse heart transplantation model.
    Ito H; Hamano K; Fukumoto T; Wood KJ; Esato K
    J Heart Lung Transplant; 1998 May; 17(5):460-9. PubMed ID: 9628564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A synthetic CD4-CDR3 peptide analog enhances skin allograft survival across a MHC class II barrier.
    Koch U; Choksi S; Marcucci L; Korngold R
    J Immunol; 1998 Jul; 161(1):421-9. PubMed ID: 9647252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo immunosuppressive effects of monoclonal antibodies specific for CD3+, CD4+, CD8+, and MHC class II positive cells.
    Stevens HP; Roche N; Hovius SE; Jonker M
    Transplant Proc; 1990 Aug; 22(4):1783-4. PubMed ID: 2143861
    [No Abstract]   [Full Text] [Related]  

  • 5. Specific immunosuppression of corneal allograft rejection by combination of anti-VLA-4 and anti-LFA-1 monoclonal antibodies in mice.
    Hori J; Isobe M; Yamagami S; Mizuochi T; Tsuru T
    Exp Eye Res; 1997 Jul; 65(1):89-98. PubMed ID: 9237869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD4+ lymphocytes play a dominant role in murine xenograft rejection.
    Pierson RN; Winn HJ; Russell PS; Auchincloss H
    Transplant Proc; 1989 Feb; 21(1 Pt 1):519. PubMed ID: 2565056
    [No Abstract]   [Full Text] [Related]  

  • 7. Xenograft rejection of class I-expressing transgenic skin is CD4-dependent and CD8-independent.
    Auchincloss H; Moses R; Conti D; Sundt T; Smith C; Sachs DH; Winn HJ
    Transplant Proc; 1990 Oct; 22(5):2335-6. PubMed ID: 2120817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism of induction of transplantation tolerance using donor antigen and anti-CD4 monoclonal antibody.
    Wood KJ; Bushell AR; Darby CR; Pearson TC; West L; Morris PJ
    Transplant Proc; 1991 Feb; 23(1 Pt 1):133-4. PubMed ID: 1990498
    [No Abstract]   [Full Text] [Related]  

  • 9. Induction of stable long-term mixed hematopoietic chimerism following nonmyeloablative conditioning with T cell-depleting antibodies, cyclophosphamide, and thymic irradiation leads to donor-specific in vitro and in vivo tolerance.
    Mapara MY; Pelot M; Zhao G; Swenson K; Pearson D; Sykes M
    Biol Blood Marrow Transplant; 2001; 7(12):646-55. PubMed ID: 11787527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of tolerance after facilitation of engraftment with a monoclonal antibody anti-MHC class II in MHC fully allogeneic transplantation.
    Hamelmann E; Wottge HU; Gassmann W; Uharek L; Müller-Ruchholtz W
    Transplant Proc; 1990 Oct; 22(5):2340-1. PubMed ID: 2219397
    [No Abstract]   [Full Text] [Related]  

  • 11. Regulation of transplantation immunity in vivo by monoclonal antibodies recognizing host class II restriction elements. II. Effects of anti-Ia immunotherapy on host T cell responses to graft alloantigens.
    Williams IR; Perry LL
    J Immunol; 1985 May; 134(5):2942-7. PubMed ID: 3156920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advantages of F(ab')2 fragments of anti-CD3 monoclonal antibody as compared to whole antibody as immunosuppressive agents in mice.
    Hirsch R; Bluestone JA; Bare CV; Gress RE
    Transplant Proc; 1991 Feb; 23(1 Pt 1):270-1. PubMed ID: 1824981
    [No Abstract]   [Full Text] [Related]  

  • 13. Mechanism of rejection of MHC class II-disparate murine skin grafts. I. Immunohistochemical analysis of T-cell subsets infiltrating the site of the graft.
    Kobayashi E; Fujiwara M
    Transplant Proc; 1992 Feb; 24(1):419-22. PubMed ID: 1531715
    [No Abstract]   [Full Text] [Related]  

  • 14. Prolonged allograft survival in anti-CD4 antibody transgenic mice: lack of residual helper T cells compared with other CD4-deficient mice.
    Han WR; Zhan Y; Murray-Segal LJ; Brady JL; Lew AM; Mottram PL
    Transplantation; 2000 Jul; 70(1):168-74. PubMed ID: 10919596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro and in vivo evidence for high frequency of I-Ab-reactive CD4+ T cells in HLA-DQ or HLA-DRA transgenic mice lacking endogenous MHC class I and/or class II expression.
    Ishimoto T; Yamamoto K; Fukui Y; Fukuda Y; Dohi K; Sasazuki T
    J Immunol; 1997 Oct; 159(8):3717-22. PubMed ID: 9378957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An immunodominant minor histocompatibility alloantigen that initiates corneal allograft rejection.
    Haskova Z; Sproule TJ; Roopenian DC; Ksander AB
    Transplantation; 2003 Apr; 75(8):1368-74. PubMed ID: 12717232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoimmunity following neonatal tolerance to alloantigens: role of donor I-A and I-E molecules.
    Kramar G; Schurmans S; Berney M; Izui S; del Giudice G; Lambert PH
    J Autoimmun; 1995 Apr; 8(2):177-92. PubMed ID: 7612147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reassessment of the role of class II antigens in skin graft rejection.
    Sachs DH; Stone K; Arn JS
    Transplant Proc; 1989 Feb; 21(1 Pt 1):595-7. PubMed ID: 2565057
    [No Abstract]   [Full Text] [Related]  

  • 19. Tolerance induction to skin allografts following intrathymic injection with donor-specific splenocytes in major histocompatibility complex class I, class I+MLS, and class I+II disparities.
    Ohzato H; Monaco AP
    Transplant Proc; 1993 Feb; 25(1 Pt 1):297-8. PubMed ID: 8438307
    [No Abstract]   [Full Text] [Related]  

  • 20. Alterations in peripheral V beta 11+ T-cell populations are not predictive of allograft rejection in I-E- mice resistant to neonatal tolerance induction.
    Nassiri M; Koh M; Padmanabhan J; Viciana A; Streilein JW; Ruiz P
    Transplant Proc; 1993 Feb; 25(1 Pt 1):368-70. PubMed ID: 8438339
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.